ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sodium hydride → [2-(6-Methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-yl]-(2-phenoxy-ethyl)-amine

HRID 1518036
印刷

反応式

HRID 1518036 の反応式
C(OC(=O)[N:7]([CH:17]1[CH2:25][CH2:24][C:23]2[C:19](=[CH:20][N:21]([C:26]3[C:35]4[C:30](=[CH:31][CH:32]=[C:33]([O:36][CH3:37])[N:34]=4)[N:29]=[CH:28][CH:27]=3)[N:22]=2)[CH2:18]1)[CH2:8][CH2:9][O:10][C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=1)(C)(C)C.C(OC(=O)NC1CCC2C(=CN(C3C4C(=CC=C(OC)N=4)N=CC=3)N=2)C1)(C)(C)C.[H-].[Na+].BrCCOC1C=CC=CC=1>CN(C=O)C.CCOC(C)=O.O>[CH3:37][O:36][C:33]1[N:34]=[C:35]2[C:30](=[CH:31][CH:32]=1)[N:29]=[CH:28][CH:27]=[C:26]2[N:21]1[CH:20]=[C:19]2[C:23]([CH2:24][CH2:25][CH:17]([NH:7][CH2:8][CH2:9][O:10][C:11]3[CH:12]=[CH:13][CH:14]=[CH:15][CH:16]=3)[CH2:18]2)=[N:22]1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 24758Sodium hydride2 回HCID 68526Benzene, (2-bromoethoxy)-2 回HCID 59560627[2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-yl]carbamic acid tert-butyl esterHCID 68497153[2-(6-Methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-yl]-(2-phenoxy-ethyl)-carbamic acid tert-butyl ester

生成物 1

HCID 11948461
[2-(6-Methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-yl]-(2-phenoxy-ethyl)-amine
収率 48%

試薬・触媒・溶媒 3

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒HCID 8857Ethyl Acetate溶媒

実験手順

[2-(6-Methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-yl]-(2-phenoxy-ethyl)-carbamic acid tert-butyl ester. To a solution of [2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-yl]-carbamic acid tert-butyl ester (104 mg, 0.260 mmol) in DMF (2.6 mL) was added NaH (60% in mineral oil, 27 mg, 0.66 mmol) at 0° C. The reaction mixture was warmed to RT and stirred for 30 min. Upon cooling the reaction mixture to 0° C., β-bromophenetole (78 mg, 0.39 mmol) was added. The mixture was warmed to RT, and treated with additional NaH (31 mg, 1.3 mmol) and β-bromophenetole (261 mg, 1.30 mmol). After 30 h, H2O (30 mL) and EtOAc (40 mL) were added to the reaction mixture. The organic layer was separated, washed with brine (20 mL), dried (MgSO4), filtered, and concentrated. The crude was purified on SiO2 (0-100% EtOAc/hexanes) to give 65 mg (48%) of the title compound as a white solid. MS (ESI): exact mass calculated for C29H33N5O4, 515.25; m/z found, 516.4 [M+H]+. 1H NMR (500 MHz, CDCl3): 9.09 (br s, 1H), 8.77 (d, J=5.0, 1H), 8.26 (d, J=9.1, 1H), 8.15 (d, J=5.0, 1H), 7.30-7.27 (m, 2H), 7.18 (d, J=9.1, 1H), 6.97-6.92 (m, 1H), 6.90 (d, J=7.8, 2H), 4.16-4.04 (m, 6H), 3.65-3.59 (m, 2H), 3.09-3.05 (m, 1H), 2.92 (br s, 3H), 2.11 (br s, 2H), 1.49 (s, 9H).

後処理

  1. temperatureUpon cooling the reaction mixture to 0° C.
  2. temperatureThe mixture was warmed to RT
  3. waitAfter 30 h
  4. customThe organic layer was separated
  5. washwashed with brine (20 mL)
  6. dry with materialdried (MgSO4)
  7. filtrationfiltered
  8. concentrationconcentrated
  9. customThe crude was purified on SiO2 (0-100% EtOAc/hexanes)

出典と根拠

ORDレコード
ord-2ce8cdd7ea56494ea5af55671d746e35
出典データセット
uspto-grants-2012_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08232391B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート